Total Debt
$32.8M
Net Debt
-$347.1M
Tango Therapeutics, Inc. currently has $32.8M in total debt. Net debt is -$347.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
TNGX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.03 | 0.38 | -0.35Net Cash | 0.44 | 7.5% |
| 2025-12-31 | 0.03 | 0.34 | -0.31Net Cash | 0.40 | 8.4% |
| 2025-09-30 | 0.03 | 0.15 | -0.12Net Cash | 0.21 | 16.5% |
| 2025-06-30 | 0.04 | 0.18 | -0.15Net Cash | 0.24 | 14.7% |
| 2025-03-31 | 0.04 | 0.22 | -0.18Net Cash | 0.27 | 13.5% |
| 2024-12-31 | 0.04 | 0.26 | -0.22Net Cash | 0.32 | 11.5% |
| 2024-09-30 | 0.04 | 0.29 | -0.26Net Cash | 0.35 | 10.7% |
| 2024-06-30 | 0.04 | 0.32 | -0.28Net Cash | 0.38 | 9.9% |
| 2024-03-31 | 0.04 | 0.34 | -0.31Net Cash | 0.41 | 9.4% |
| 2023-12-31 | 0.04 | 0.34 | -0.30Net Cash | 0.40 | 9.7% |
| 2023-09-30 | 0.04 | 0.36 | -0.32Net Cash | 0.43 | 9.2% |
| 2023-06-30 | 0.04 | 0.31 | -0.27Net Cash | 0.38 | 10.5% |
| 2023-03-31 | 0.04 | 0.33 | -0.29Net Cash | 0.40 | 10.2% |
| 2022-12-31 | 0.04 | 0.37 | -0.33Net Cash | 0.44 | 9.4% |
| 2022-09-30 | 0.04 | 0.39 | -0.35Net Cash | 0.46 | 8.8% |
| 2022-06-30 | 0.00 | 0.42 | -0.42Net Cash | 0.45 | 0.1% |
| 2022-03-31 | 0.00 | 0.45 | -0.45Net Cash | 0.47 | 0.2% |
| 2021-12-31 | 0.00 | 0.49 | -0.48Net Cash | 0.50 | 0.3% |
| 2021-09-30 | 0.01 | 0.50 | -0.50Net Cash | 0.53 | 1.4% |
| 2021-06-30 | 0.01 | 0.20 | -0.19Net Cash | 0.22 | 3.4% |
| 2021-03-31 | 0.01 | 0.21 | -0.20Net Cash | 0.22 | 3.4% |
| 2020-12-31 | 0.01 | 0.19 | -0.18Net Cash | 0.21 | 3.8% |
| 2020-09-30 | 0.00 | 0.00 | -0.00Net Cash | 0.17 | 0.0% |
| 2020-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 39.4% |
| 2020-03-31 | 0.00 | 0.04 | -0.04Net Cash | 0.00 | — |